• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Interpreting Prostate MRI Reports in the Era of Increasing Prostate MRI Utilization: A Urologist's Perspective.在前列腺MRI应用日益增多的时代解读前列腺MRI报告:泌尿外科医生的视角
Diagnostics (Basel). 2024 May 20;14(10):1060. doi: 10.3390/diagnostics14101060.
2
Prostate MRI: staging and decision-making.前列腺 MRI:分期与决策。
Abdom Radiol (NY). 2020 Jul;45(7):2143-2153. doi: 10.1007/s00261-020-02431-8.
3
ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists' training.ESUR/ESUI 共识声明:多参数 MRI 检测临床显著前列腺癌:图像采集、解读和放射科医生培训的质量要求。
Eur Radiol. 2020 Oct;30(10):5404-5416. doi: 10.1007/s00330-020-06929-z. Epub 2020 May 19.
4
Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review.影响多参数磁共振成像检测临床显著前列腺癌性能变异性的因素:系统文献回顾。
Eur Urol Oncol. 2020 Apr;3(2):145-167. doi: 10.1016/j.euo.2020.02.005. Epub 2020 Mar 17.
5
Measuring the Quality of Diagnostic Prostate Magnetic Resonance Imaging: A Urologist's Perspective.测量前列腺磁共振成像诊断质量:泌尿科医生的视角。
Eur Urol. 2021 Apr;79(4):440-441. doi: 10.1016/j.eururo.2020.09.015. Epub 2020 Sep 18.
6
The urologist's learning curve of "in-bore" magnetic resonance-guided prostate biopsy.泌尿科医生在“腔内”磁共振引导前列腺活检中的学习曲线。
BMC Urol. 2021 Dec 6;21(1):169. doi: 10.1186/s12894-021-00936-y.
7
Prostate MRI and image quality: The urologist's perspective.前列腺 MRI 与图像质量:泌尿科医生的视角。
Eur J Radiol. 2024 Jan;170:111255. doi: 10.1016/j.ejrad.2023.111255. Epub 2023 Dec 9.
8
Magnetic resonance imaging in prostate cancer detection and management: a systematic review.磁共振成像在前列腺癌检测与管理中的应用:一项系统综述。
Minerva Urol Nefrol. 2017 Dec;69(6):567-578. doi: 10.23736/S0393-2249.17.02819-3. Epub 2017 May 8.
9
Integrated 68Gallium Labelled Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Magnetic Resonance Imaging Enhances Discriminatory Power of Multi-Parametric Prostate Magnetic Resonance Imaging.整合68镓标记的前列腺特异性膜抗原-11正电子发射断层扫描/磁共振成像增强了多参数前列腺磁共振成像的鉴别能力。
Urol Int. 2018;100(2):164-171. doi: 10.1159/000484695. Epub 2018 Jan 25.
10
Innovative standardized reporting template for prostate mpMRI improves clarity and confidence in the report.创新性标准化前列腺 mpMRI 报告模板可提高报告的清晰度和信心。
World J Urol. 2021 Jul;39(7):2447-2452. doi: 10.1007/s00345-020-03487-3. Epub 2020 Oct 20.

引用本文的文献

1
Predicting uninformative prostate magnetic resonance imaging sequences: a hypothesis-generating pilot study.预测无信息价值的前列腺磁共振成像序列:一项产生假设的初步研究。
Radiol Bras. 2025 Jul 17;58:e20250007. doi: 10.1590/0100-3984.2025.0007. eCollection 2025 Jan-Dec.

本文引用的文献

1
Low cancer yield in PI-RADS 3 upgraded to 4 by dynamic contrast-enhanced MRI: is it time to reconsider scoring categorization?动态对比增强 MRI 升级为 PI-RADS 4 的 PI-RADS 3 级肿瘤中癌症的检出率较低:是否是时候重新考虑评分分类了?
Eur Radiol. 2023 Aug;33(8):5828-5839. doi: 10.1007/s00330-023-09605-0. Epub 2023 Apr 13.
2
Impact of prebiopsy MRI on prostate cancer staging: Results from the Norwegian Prostate Cancer Registry.活检前磁共振成像对前列腺癌分期的影响:来自挪威前列腺癌登记处的结果。
BJUI Compass. 2023 Jan 10;4(3):331-338. doi: 10.1002/bco2.214. eCollection 2023 May.
3
The impact of local staging of prostate cancer determined on MRI or DRE at time of radical prostatectomy on progression-free survival: A Will Rogers phenomenon.根治性前列腺切除术前 MRI 或 DRE 检测时局部分期对无进展生存的影响:Will Rogers 现象。
Urol Oncol. 2023 Feb;41(2):106.e9-106.e16. doi: 10.1016/j.urolonc.2022.10.023. Epub 2022 Dec 21.
4
PSA density is complementary to prostate MP-MRI PI-RADS scoring system for risk stratification of clinically significant prostate cancer.PSA 密度对于前列腺 MRI PI-RADS 评分系统在临床上有意义的前列腺癌风险分层具有互补作用。
Prostate Cancer Prostatic Dis. 2023 Jun;26(2):347-352. doi: 10.1038/s41391-022-00549-y. Epub 2022 May 6.
5
ACR-RADS Programs Current State and Future Opportunities: Defining a Governance Structure to Enable Sustained Success.ACR-RADS 项目现状与未来机遇:建立治理结构以实现持续成功
J Am Coll Radiol. 2022 Jun;19(6):782-791. doi: 10.1016/j.jacr.2022.03.012. Epub 2022 Apr 26.
6
PI-RADS v2.1: What has changed and how to report.前列腺影像报告和数据系统(PI-RADS)v2.1:有哪些变化及如何报告。
SA J Radiol. 2021 Jun 1;25(1):2062. doi: 10.4102/sajr.v25i1.2062. eCollection 2021.
7
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
8
Diagnostic pathway of the biopsy-naïve patient suspected for prostate cancer: Real-life scenario when multiparametric Magnetic Resonance Imaging is not centralized.疑似前列腺癌的未经活检患者的诊断途径:多参数磁共振成像未集中时的实际情况。
Prog Urol. 2021 Oct;31(12):739-746. doi: 10.1016/j.purol.2020.12.008. Epub 2021 Jan 9.
9
Fusion US/MRI prostate biopsy using a computer aided diagnostic (CAD) system.融合式 US/MRI 前列腺活检采用计算机辅助诊断 (CAD) 系统。
Minerva Urol Nephrol. 2021 Oct;73(5):616-624. doi: 10.23736/S2724-6051.20.04008-4. Epub 2020 Nov 12.
10
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.EAU-EANM-ESTRO-ESUR-SIOG 前列腺癌指南-2020 版更新。第 1 部分:筛查、诊断和以治愈为目的的局部治疗。
Eur Urol. 2021 Feb;79(2):243-262. doi: 10.1016/j.eururo.2020.09.042. Epub 2020 Nov 7.

在前列腺MRI应用日益增多的时代解读前列腺MRI报告:泌尿外科医生的视角

Interpreting Prostate MRI Reports in the Era of Increasing Prostate MRI Utilization: A Urologist's Perspective.

作者信息

Miszewski Kevin, Skrobisz Katarzyna, Miszewska Laura, Matuszewski Marcin

机构信息

Department of Urology, Gdańsk Medical University, Mariana Smoluchowskiego 17 Street, 80-214 Gdańsk, Poland.

Department of Radiology, Gdańsk Medical University, Mariana Smoluchowskiego 17 Street, 80-214 Gdańsk, Poland.

出版信息

Diagnostics (Basel). 2024 May 20;14(10):1060. doi: 10.3390/diagnostics14101060.

DOI:10.3390/diagnostics14101060
PMID:38786358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11120165/
Abstract

Multi-parametric prostate MRI (mpMRI) is crucial for diagnosing, staging, and assessing treatment response in individuals with prostate cancer. Radiologists, through an accurate and standardized interpretation of mpMRI, stratify patients who may benefit from more invasive treatment or exclude patients who may be harmed by overtreatment. The integration of prostate MRI into the diagnostic pathway is anticipated to generate a substantial surge in the demand for high-quality mpMRI, estimated at approximately two million additional prostate MRI scans annually in Europe. In this review we examine the immediate impact on healthcare, particularly focusing on the workload and evolving roles of radiologists and urologists tasked with the interpretation of these reports and consequential decisions regarding prostate biopsies. We investigate important questions that influence how prostate MRI reports are handled. The discussion aims to provide insights into the collaboration needed for effective reporting.

摘要

多参数前列腺磁共振成像(mpMRI)对于前列腺癌患者的诊断、分期和治疗反应评估至关重要。放射科医生通过对mpMRI进行准确和标准化的解读,对可能从更具侵入性治疗中获益的患者进行分层,或排除可能因过度治疗而受到伤害的患者。预计将前列腺MRI纳入诊断流程会使对高质量mpMRI的需求大幅增加,据估计在欧洲每年额外需要约200万次前列腺MRI扫描。在本综述中,我们研究了对医疗保健的直接影响,特别关注负责解读这些报告以及做出有关前列腺活检相应决策的放射科医生和泌尿科医生的工作量及角色演变。我们调查了影响前列腺MRI报告处理方式的重要问题。讨论旨在深入了解有效报告所需的协作。